Prof D Gareth Evans MB BS MD FRCP FLSW FRCOG ad eundem

Clinical Professor of Med Gen and Cancer

View graph of relations


Professor of Medical Genetics and Cancer Epidemiology, The University of Manchester

Consultant in Medical Genetics and Cancer Epidemiology, Central Manchester Hospitals NHS Foundation Trust and The Christie NHS Foundation Trust


Professor Evans has established a national and international reputation in clinical and research aspects of cancer genetics, particularly in neurofibromatosis and breast cancer. He has developed a clinical service for cancer genetics in the North West Region of England, which is nationally regarded. He is an important opinion leader nationally through membership of committees and was chairman of the NICE Familial Breast Cancer Guideline Development Group (2002-2010) and is now clinical lead (2011-). He lectures throughout the UK and internationally on hereditary breast cancer and cancer syndromes. He has given plenary lectures at many international meetings including the International Congress of Human Genetics and two invited lecture tours across Australia (1995, 2001). He has developed a national training program for clinicians, nurses and genetic counsellors in breast cancer genetics and established a system for risk assessment and counselling for breast cancer in Calman breast units implemented through a training course (1998-2011).


He has published 920 peer reviewed research publications; 327 as first or senior author. He has published over 150 reviews and chapters and has had a book published by Oxford University Press on familial cancer. He has an ISI web of knowledge H-index of 118 and a google scholar H-index of 159 having only published his first article in 1990. In the last 5 years he has raised over £35 million in grants for multicentre and local studies – approximately £31 million to Manchester. He is Chief Investigator on two (£1.59 & £1 million) NIHR program grant (2009-2014 and 2016-2020) on breast cancer risk prediction and also has an NIHR RfPB grant as CI (2011).  He has led a successful bid for a Nationally funded NF2 service (£7.5 million pa) that started in 2010 and is involved in the national complex NF1 service. He is theme lead and cancer lead on the All Manchester NIHR Biomedical Research Centre worth £28.5 Million (2016-2020). He was elected a fellow of the learned Society of Wales (FLSW) in 2020 and FRCOG ad eundem in 2021

Research interests

  • inherited breast and ovarian cancer and its imaging and prevention
  • Neurofibromatosis types 1 and 2 and imaging
  • Other inherited tumour predispositions


Social responsibility

Director Nannerch Players

Ex Trustee Breast Cancer Now

Ex Trustee Neuro Foundation now chairman of Medical Advisory Board

Ex Trustee Hereditary Breast Cancer Helpline now medical advisor

Scientific Advisory Board Member Bowel Cancer UK

Trustee CB Wilson Trust

Trustee NF2 Biosolutions UK

Trustee Frances B Thornily  (FBT) trust

Advisor The Gorlin Group Scientific Advisor Prevent Breast Cancer 



Memberships of committees and professional bodies

Member and Ex Council Member of the Clinical Genetics Society

Member and Ex Chairman of the Cancer Genetics Group

Member and ex Council Member of the British Society of Genomic Medicine

Member European Society of Human Genetics


Research Beacons, Institutes and Platforms

Sustainable Development Goals

Related information


Activity: Publication peer-review and editorial workEditorial work

View all (1)

Student Theses

UoM administered thesis: Phd

UoM administered thesis: Doctor of Medicine

View all (6)


Prize: Prize (including medals and awards)

Prize: Prize (including medals and awards)

Prize: Prize (including medals and awards)

View all prizes (4)